Your browser doesn't support javascript.
loading
O-linked N-acetylglucosamine transferase (OGT) regulates pancreatic α-cell function in mice.
Essawy, Ahmad; Jo, Seokwon; Beetch, Megan; Lockridge, Amber; Gustafson, Eric; Alejandro, Emilyn U.
Afiliação
  • Essawy A; Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Jo S; Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Beetch M; Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Lockridge A; Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Gustafson E; Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Alejandro EU; Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN, USA. Electronic address: ealejand@umn.edu.
J Biol Chem ; 296: 100297, 2021.
Article em En | MEDLINE | ID: mdl-33460647
ABSTRACT
The nutrient sensor O-GlcNAc transferase (OGT) catalyzes posttranslational addition of O-GlcNAc onto target proteins, influencing signaling pathways in response to cellular nutrient levels. OGT is highly expressed in pancreatic glucagon-secreting cells (α-cells), which secrete glucagon in response to hypoglycemia. The objective of this study was to determine whether OGT is necessary for the regulation of α-cell mass and function in vivo. We utilized genetic manipulation to produce two α-cell specific OGT-knockout models a constitutive glucagon-Cre (αOGTKO) and an inducible glucagon-Cre (i-αOGTKO), which effectively delete OGT in α-cells. Using approaches including immunoblotting, immunofluorescent imaging, and metabolic phenotyping in vivo, we provide the first insight on the role of O-GlcNAcylation in α-cell mass and function. αOGTKO mice demonstrated normal glucose tolerance and insulin sensitivity but displayed significantly lower glucagon levels during both fed and fasted states. αOGTKO mice exhibited significantly lower α-cell glucagon content and α-cell mass at 6 months of age. In fasting, αOGTKO mice showed impaired pyruvate stimulated gluconeogenesis in vivo and reduced glucagon secretion in vitro. i-αOGTKO mice showed similarly reduced blood glucagon levels, defective in vitro glucagon secretion, and normal α-cell mass. Interestingly, both αOGTKO and i-αOGTKO mice had no deficiency in maintaining blood glucose homeostasis under fed or fasting conditions, despite impairment in α-cell mass and function, and glucagon content. In conclusion, these studies provide a first look at the role of OGT signaling in the α-cell, its effect on α-cell mass, and its importance in regulating glucagon secretion in hypoglycemic conditions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicemia / Glucagon / N-Acetilglucosaminiltransferases / Células Secretoras de Glucagon / Obesidade Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicemia / Glucagon / N-Acetilglucosaminiltransferases / Células Secretoras de Glucagon / Obesidade Idioma: En Ano de publicação: 2021 Tipo de documento: Article